Newsroom

In US FTC’s GTCR case, focus on PE rollups replaced by traditional M&A review

White & Case advises Merck KGaA on agreement to acquire life science company Mirus Bio for US$600 million

White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC

Amgen-Horizon Therapeutics second request by US FTC could address pipeline drugs

White & Case Advises NRG Energy, Inc. on its US$2.8 Billion Acquisition of Vivint Smart Home, Inc.